Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, leading to reduced prostaglandin synthesis. The enteric coating is designed to prevent dissolution in the stomach, thereby reducing gastric irritation.
## Primary Indications
* **Pain relief:** Mild to moderate pain.
* **Inflammation reduction:** Inflammatory conditions.
* **Antiplatelet therapy:** Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease, peripheral arterial disease, or at high risk for these events. This indication is typically for low-dose aspirin.
## Adult Dosing
* **Pain and Inflammation:**
* Typically 325 mg to 1000 mg orally every 4 to 6 hours as needed.
* Maximum daily dose generally not to exceed 4000 mg.
* **Antiplatelet Therapy:**
* 30 mg to 325 mg orally once daily. Specific dose is often guided by cardiology guidelines and patient risk factors.
## Pediatric Dosing
* **Pain and Inflammation:** Aspirin is generally **not recommended** in children and adolescents for viral infections or febrile illness due to the risk of Reye's syndrome. Use in pediatric populations for other indications should be under strict medical supervision and guided by specialist recommendations.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised. Patients with severe impairment should be monitored closely for adverse effects.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* Children and adolescents with viral infections or fever (risk of Reye's syndrome).
* Hemophilia, thrombocytopenia, or other bleeding disorders.
* Severe hepatic or renal impairment.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, GI bleeding, ulceration, perforation.
* **Hematologic:** Increased bleeding time, bruising, petechiae, epistaxis, prolonged bleeding from cuts.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema, rash, anaphylaxis.
* **Other:** Tinnitus (especially at higher doses), dizziness, confusion, headache, drowsiness.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** Aspirin may decrease their efficacy and increase risk of renal impairment.
* **Methotrexate:** Aspirin can increase methotrexate toxicity by decreasing its renal clearance.
* **Uricosuric agents (e.g., probenecid):** Aspirin can interfere with the uricosuric effect.
* **Alcohol:** Increased risk of GI bleeding.
## Monitoring
* Monitor for signs and symptoms of GI bleeding (e.g., melena, hematemesis, abdominal pain).
* Monitor for signs of bruising or excessive bleeding.
* Assess for tinnitus or hearing changes, which can indicate salicylate toxicity.
* For antiplatelet therapy, monitor for cardiovascular events.
## Clinical Pearls
* The enteric coating reduces gastric irritation but does not eliminate the risk of GI bleeding or ulceration, particularly with chronic use or higher doses.
* If rapid pain relief is needed, an immediate-release formulation may be preferred, as enteric-coated aspirin may have a delayed onset of action.
* Discontinue aspirin several days before elective surgery to minimize bleeding risk, as per surgical or anesthetic guidance.
* For antiplatelet use, adherence to the prescribed low dose is crucial.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the current prescribing information and relevant guidelines for complete details. Verify dosages and indications based on the specific patient and local protocols.*
